International collaborative treatment protocol for infants under one year with KMT2Arearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia (Interfant-21)
2024-08-01
عنوان الدراسة
International collaborative treatment protocol for infants under one year with KMT2Arearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia (Interfant-21)
داعم الدراسة
King Abdullah International Medical Research Center (KAIMRC)
دواء الدراسة
BLINATUMOMAB
رقم بروتوكول الدراسة
SCT22R/016/12
حالة الدراسة
Ongoing
موقع الدراسة
King Abdulaziz Medical City NG (Riyadh),King Abdulaziz Medical City NG (Jeddah)
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。